News & Events
- News coverage of our programs
-
HBF Reports and Publications
-
Hep B Press Releases
- WHO announces new guidelines for hepatitis B treatment
- Hepatitis B Foundation presents globally recognized liver disease expert with 2024 Baruch S. Blumberg Prize
- Hepatitis B Foundation releases new campaign highlighting the connection between hepatitis B and liv
- Hepatitis B Foundation releases report on first-ever Externally Led Patient-Focused Drug Development meeting for hepatitis B
- Hepatitis B Foundation presents globally recognized liver disease expert with 2024 Baruch S. Blumberg Prize
- People living with hepatitis B should have a voice in new treatment guidelines, advocates say
- Hepatitis B Foundation launches training website with user-friendly courses for everyone interested in hepatitis B and D
- Pennsylvania couple receives Hepatitis B Foundation’s Community Leadership Award
- Hepatitis B Foundation, Blumberg Institute and PABC congratulates John Crowley of Amicus on being named BIO President and CEO
- Hepatitis B Foundation extends its engagement in Africa
- Sen. Steven J. Santarsiero honored at the Pennsylvania Biotechnology Center (PABC)
- Hepatitis B Foundation invites providers and the public to participate in The Liver Meeting, Nov. 10-14, in Boston and online
- Hepatitis B Foundation coordinates 2023 International HBV Meeting, a scientific conference held Sept. 19-23 in Kobe, Japan
- Hep B United Commemorates World Hepatitis Day, July 28
- Gala puts the spotlight on creating family and support for those living with hepatitis B
- Global leader, physician treating people living with hepatitis B takes new role with Hepatitis B Foundation
- Hepatitis B Foundation releases white paper calling health care providers into action following new hepatitis B screening and vaccination recommendations
- New CDC Universal Screening Recommendations will save lives, Hepatitis B Foundation president says
- Hepatitis B Foundation invites everyone to participate in the online silent auction fundraiser.
- Hepatitis B Foundation president responds to Janssen decision on the company’s hepatitis B drug development program
- Globally prominent advocate and physician chosen for Hepatitis B Foundation’s 2023 Community Commitment Award
- Dr. Yasmin Ibrahim appointed to national Patient Engagement Collaborative
- Comprehensive hepatitis B program in Vietnam provides an excellent model for other countries
- Hepatitis B Foundation Announces third series of continuing education program on hepatitis B for health care providers and public health professionals
- Hepatitis B Foundation hails decision by U.S. Public Health Service Corps to accept future applicants living with chronic hepatitis B infection and HIV
- German scientist, inventor of new, first-in-class treatment for hepatitis D, to receive the 2023 Baruch S. Blumberg Prize
- Researchers and people living with hepatitis B meet in Paris at the third Hepatitis B Community Forum
- Hepatitis B Foundation mourns Bill Mason, an accomplished scientist whose discovery led to current treatments for hepatitis B
- Hepatitis B Foundation raises alarm about findings from new federal viral hepatitis surveillance report
- Hepatitis B Foundation strongly supports Congressional letters urging Biden administration to end discriminatory military policy
- Longtime Board Chair honored by his colleagues
- Hepatitis B Foundation creates two Global Community Advisory Boards
- Pa DOH Highlights the Importance of Viral Hepatitis Awareness, Need for Expansion of Syringe Services
- Hepatitis B Foundation, StoryCenter release new #justB stories from people with lived experience
- Pediatric Hepatitis Outbreaks
- Philadelphia City Council recognizes May as Hepatitis Awareness Month
- Hepatitis B Foundation hosts Princeton Workshop on Liver Cancer
- Annual Gala raises a record amount for the local Hepatitis B Foundation
- Hepatitis D Roundtable to Address Unmet Needs of Patients
- DiRx teams up with Hepatitis B Foundation to offer low-cost medications
- Many more U.S. adults to get vaccinated against hepatitis B following move by U.S. Centers for Disease Control and Prevention (CDC)
- Hepatitis B Foundation receives Congressional funding for a Center of Public Health Excellence
- CTC Foundation of Princeton donating $100,000 to Hepatitis B Foundation
- Hepatitis B Foundation senior vice president and board member speak on popular podcast
- Anonymous donor provides record gift for hepatitis B research
- Two hepatitis B medications available free through Hepatitis B Foundation and Rx Outreach partnership
- Canadian scientist chosen for the 2022 Hepatitis B Foundation’s Blumberg Prize
- Landmark vote by CDC’s Advisory Committee on Immunization Practices (ACIP) to recommend universal hepatitis B vaccination
- Hepatitis B Foundation strongly endorses the Liver Illness Visibility, Education and Research (LIVER) Act of 2021
- Dr. Chari A. Cohen becomes President of the Hepatitis B Foundation
- New president announced for the Pennsylvania Biotechnology Center (PABC)
- Major successes on Capitol Hill
- CDC awards a $1.375 million, five-year grant to the Hepatitis B Foundation for expansion of Hep B United, a nationwide coalition
- Hepatitis B Foundation Members Selected to Participate as Consumer Reviewers in the Congressionally Directed Medical Research Program’s Peer Reviewed Medical Research Program for the U.S. Department of Defense
- Hepatitis B Foundation supports launch of new global online forum dedicated to supporting people with hepatitis B, connecting with health experts
- Hepatitis B Foundation launches the first global registry of discrimination against people living with hepatitis B
- Hepatitis B Foundation to hold its annual Crystal Ball Gala on April 30
- Hepatitis B Foundation mourns the passing of John C. Martin, pharmaceutical industry leader
- Chronic hepatitis B is far more prevalent among U.S. residents than previously reported
- All of Us research program
- Hepatitis B Foundation Mourns Loss of Co-Founder Paul Witte, Longtime New Hope Resident
- Hepatitis B Foundation launches continuing education series on hepatitis B for health care providers and public health professionals
- HBF applauds President Biden’s Memorandum denouncing racism, xenophobia, and intolerance against Asian Americans and Pacific Islanders
- Hepatitis B Foundation applauds release of National Hepatitis Strategic Plan
- Bristol Myers Squibb awards grant to Hepatitis B Foundation
- Federal Task Force Recommendation for Hepatitis B Screening Fails to Close Gaps in Diagnosis Rates
- Hepatitis B community leaders convene to address eliminating hepatitis B during COVID-19 pandemic
- Pennsylvania Biotechnology Center’s Kassa named one of The 10 Best COOs of 2020
- Hepatitis B Foundation announces recipient of 2021 Baruch S. Blumberg Prize
- Hepatitis B Foundation co-founders chosen for major new award from the American Association for the Study of Liver Diseases
- Hepatitis B Foundation applauds HHS letter on discrimination against people living with hepatitis B who are pursuing careers in health care
- Hepatitis B Foundation launches new tool to assist people living with hepatitis B in making decisions on health insurance
- Hepatitis B Foundation receives Congressional funding for a Center of Public Health Excellence
- Nobel Prize to Hepatitis B Foundation and Blumberg Institute Advisors
- Work begins on a $19 million expansion of the Pennsylvania Biotechnology Center (PABC)
- Hepatitis B Foundation launches B the Voice Story Bank
- Hepatitis B Foundation expresses appreciation for the work of Dr. Ding-Shinn Chen with the announcement of his death
- Hepatitis B Foundation and Hep B United Statement on the Federal Government's Rollback of Critical Health Care Protections
- Hepatitis B Foundation stands in solidarity with black communities, calls for action against institutional racism
- Two Powerful Editorials Published by the Hepatitis B Foundation
- Hepatitis B Foundation Expands Hepatitis B Prevention Policy Initiatives
- HBV Vaccinations Save Lives, Reduce New Infections: National Adult Hepatitis B Vaccination Awareness Day
- Hepatitis B Foundation Hepatitis B Foundation Says “Thank You!” to its 100- Volunteers
- Hepatitis B Foundation Announces Annual Fundraising Event to Go Virtual on April 24
- Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center Announce New Director of Communications and Marketing
- Message from Dr. Timothy Block, Hepatitis B Foundation President
- Hepatitis B Foundation Commends New Rx Outreach Program to Provide Access to Affordable Hepatitis B Medication
- Hepatitis B Foundation Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2019
- Hepatitis B Foundation Announces 2020 Baruch S. Blumberg Prize Winner
- U.S. Falls Short in Reaching 2020 Goals for Hepatitis B
- Hepatitis B Foundation Calls for Increased Resources for Hepatitis B Prevention in Response to CDC 2017 Surveillance Data Report
- Our Voices Made a Difference: CVS Caremark to Cover Vemlidy Prescriptions
- Hepatitis B Foundation Announces 2019 Baruch S. Blumberg Prize Winner
- Hep B United Applauds Bipartisan Legislation to Combat the Opioid Crisis and Opioid Related Infectious Diseases
- Hepatitis B Foundation Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2018
- Hepatitis B Foundation Calls for Universal Screening for Hepatitis B
- Hepatitis B Leaders Call for the Elimination of Hepatitis B
- Hepatitis B Foundation Joins Forces with Grace Meng
- Hepatitis B Foundation Releases New #justB Stories
- Hepatitis B community leaders convene to address eliminating hepatitis B during COVID-19 pandemic
- Hepatitis B Foundation Strongly Supports the Strategic Plan for Trans‐NIH Research to Cure Hepatitis B
- Hepatitis B Foundation Crystal Ball Gala
- New Two-Dose HBV Vaccine Recommended by ACIP
- Timothy M. Block, PhD, President of Hepatitis B Foundation and its Baruch S. Blumberg Institute, named a 2017 National Academy of Inventors Fellow
- Hepatitis B Foundation Applauds FDA Approval of New Hepatitis B Vaccine
- CDC National Progress Report on Hepatitis Elimination Reveals Rise in Acute HBV Infections and Low Birth Dose Vaccination Rates in the U.S.
- Hepatitis B Foundation Announces Promotion of Chari Cohen, DrPH, MPH, to Vice President, Public Health and Programs
- Hepatitis B Foundation Mourns the Loss of Pioneering Hepatitis B Physician-Scientist Dr. W. Thomas London
- Hepatitis B Foundation's #justB Campaign Gives Voice to Personal Stories During May Hepatitis Awareness Month
- Executive Director Retires After 25 Years of Service
- Hepatitis B Foundation Bets on a Cure at the 2017 Crystal Ball
- Targets to Eliminate Hepatitis B in U.S.
- Fred Beans Family of Dealerships Donates $30,000..
- International Leaders to Its Scientific and Medical Advisory Board
- Hepatitis B Foundation Opposes the American Health Care Act
- Appoints Global Expert Dr. Nat Brown
- Hepatitis B Foundation Launches #justB Storytelling Campaign
- Dr. Richard G. Pestell Joins the Baruch S. Blumberg Institute
- Dr. Bud Tennant Leaves Behind a Distinguished Scientific Legacy
- Be About It
- Nationwide Hepatitis Delta Virus (HDV) Campaign
-
Free Newsletters
- Calendar of Events
- Witte Lecture
- International HBV Meeting
- Externally Led Patient-Focused Drug Development
-
World Hepatitis Day
- NYC Marathon
-
Princeton Workshop
- Commentary on the Cure
-
Awards and Events
-
COVID-19 Update
Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center Announce New Director of Communications and Marketing
Doylestown, April 8, 2020 − The Hepatitis B Foundation, a global nonprofit, recently appointed Edward F. Tate III, a Newtown resident, as director of communications and marketing.
Along with leading the foundation’s communications and marketing, Tate also will handle those functions for the Baruch S. Blumberg Institute and the Pennsylvania Biotechnology Center (PABC). The Hepatitis B Foundation created both the world-renowned Blumberg Institute and the PABC to expand its research toward a cure goal. The PABC now is among the nation’s best life sciences incubators, according to a 2018 study from the International Business Innovation Association. The Blumberg Institute has become one of the nation’s leading centers for translational research, particularly for hepatitis B and liver cancer.
All three organizations are innovative and integrated nonprofits that share a campus in Doylestown.
“Ed is a welcome addition to the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center, especially during this challenging time, when clear communication is critical,” said Timothy M. Block, Ph.D., President and CEO of all three nonprofit organizations. “His experience and expertise will help us strengthen and grow our local and national communications.”
Tate comes to the foundation from a pharmaceutical and medical technology trade association. Previously he was director of communications for Rutgers University’s Office of Research and Economic Development, executive vice president of a Philadelphia-area public relations agency and director of media relations for Educational Testing Service in Princeton.
About the Hepatitis B Foundation: The Hepatitis B Foundation is the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to www.hepb.org, read our blog at hepb.org/blog, follow us on Twitter @HepBFoundation, find us on Facebook at facebook.com/hepbfoundation or call 215‐489‐4900.